Taro-Acitretin, Capsules
« Back to list view

Product Information

  • DIN:
    02466074
  • Active Ingredients :
    acitretin
  • Innovator Name:
    Soriatane ®
  • Category:
    Keratinization Disorder Treatment
  • Dosage form:
    Capsule
  • Strength:
    10 mg
  • Route of Administration:
    Oral
  • Colour:
    brown and white
  • Markings:
    “024” in black lettering
  • Package size:
    30 Blister
  • UPC Code:
    063691081611
  • Description :
    Brown and white capsules with “024” in black lettering
  • Non-medicinal ingredients :
    Ammonium hydroxide, gelatin, iron oxide black, iron oxide red, iron oxide yellow, maltodextrin, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, sorbic acid, and titanium dioxide
Taro-Acitretin, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02466082
  • Active Ingredients :
    acitretin
  • Innovator Name:
    Soriatane ®
  • Category:
    Keratinization Disorder Treatment
  • Dosage form:
    Capsule
  • Strength:
    25 mg
  • Route of Administration:
    Oral
  • Colour:
    brown and yellow
  • Markings:
    “025” in black lettering
  • Package size:
    30 Blister
  • UPC Code:
    063691081581
  • Description :
    Brown and yellow capsules with “025” in black lettering
  • Non-medicinal ingredients :
    Ammonium hydroxide, gelatin, iron oxide black, iron oxide red, iron oxide yellow, maltodextrin, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, sorbic acid, and titanium dioxide
Taro-Acitretin, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here